-
1دورية أكاديمية
المؤلفون: Maity, Palash C., Bilal, Mayas, Koning, Marvyn T., Young, Marc, van Bergen, Cornelis A. M., Renna, Valerio, Nicolo, Antonella, Datta, Moumita, Gentner-Göbel, Eva, Barendse, Rob S., Somers, Sebastiaan F., de Groen, Ruben A. L., Vermaat, Joost S. P., Steinbrecher, Daniela, Schneider, Christof, Tausch, Eugen, Bittolo, Tamara, Bomben, Riccardo, Mazzarello, Andrea Nicola, del Poeta, Giovanni, Kroes, Wilma G. M., van Wezel, J. Tom, Imkeller, Katharina, Busse, Christian E., Degano, Massimo, Bakchoul, Tamam, Schulz, Axel Ronald, Mei, Henrik, Ghia, Paolo, Kotta, Konstantia, Stamatopoulos, Kostas, Wardemann, Hedda, Zucchetto, Antonella, Chiorazzi, Nicholas, Gattei, Valter, Stilgenbauer, Stephan, Veelken, Hendrik, Jumaa, Hassan
مصطلحات موضوعية: chronic lymphocytic leukemia (CLL), B cell antigen receptor (BCR), autonomous BCR signaling, immunoglobulin allele IGLV3-21*01, CD38 EXPRESSION, IMMUNOGLOBULIN HEAVY, PROGNOSTIC INDEX, GENES, DELETIONS, LENGTH, 13Q14, DDC 570 / Life sciences, DDC 610 / Medicine & health, Leukemia, Lymphocytic, Chronic, B-Cell, Receptors, Antigen, Immunoglobulins, Immunophenotyping, Antigens, CD, Immunogenetic phenomena, Survival, Prognosis, Chronisch-lymphatische Leukämie, B-Lymphozyten-Rezeptor, Antigen CD38, Immunglobuline
وصف الملف: application/pdf
العلاقة: http://dx.doi.org/10.18725/OPARU-49041Test; https://oparu.uni-ulm.de/xmlui/123456789/49117Test; http://nbn-resolving.de/urn:nbn:de:bsz:289-oparu-49117-6Test
الإتاحة: https://doi.org/10.18725/OPARU-49041Test
https://oparu.uni-ulm.de/xmlui/123456789/49117Test
http://nbn-resolving.de/urn:nbn:de:bsz:289-oparu-49117-6Test -
2دورية أكاديمية
المؤلفون: Carlo-Stella, C., Zinzani, P.L., Sureda, A., Araujo, L., Casasnovas, O., Carpio, C., Yeh, S.P., Bouabdallah, K., Cartron, G., Kim, W.S., Cordoba, R., Koh, Y., Re, A., Alves, D., Chamuleau, M., Le Gouill, S., Lopez-Guillermo, A., Moreira, I., van der Poel, M.W.M., Abbadessa, G., Meng, R., Ji, R., Lepine, L., Saleem, R., Ribrag, V.
المصدر: Carlo-Stella , C , Zinzani , P L , Sureda , A , Araujo , L , Casasnovas , O , Carpio , C , Yeh , S P , Bouabdallah , K , Cartron , G , Kim , W S , Cordoba , R , Koh , Y , Re , A , Alves , D , Chamuleau , M , Le Gouill , S , Lopez-Guillermo , A , Moreira , I , van der Poel , M W M , Abbadessa , G , Meng , R , Ji , R , Lepine , L ....
مصطلحات موضوعية: cemiplimab, diffuse large B-cell lymphoma, isatuximab, non-Hodgkin lymphoma, peripheral T-cell lymphoma, MULTIPLE-MYELOMA, HODGKIN-LYMPHOMA, BRENTUXIMAB VEDOTIN, CD38 EXPRESSION, CELL LYMPHOMA, BONE-MARROW, NIVOLUMAB, SAR650984
العلاقة: https://cris.maastrichtuniversity.nl/en/publications/5d163f18-ed7b-45ef-b334-d47a337fea84Test
الإتاحة: https://doi.org/10.1002/hon.3089Test
https://cris.maastrichtuniversity.nl/en/publications/5d163f18-ed7b-45ef-b334-d47a337fea84Test -
3دورية أكاديمية
المؤلفون: García-Guerrero, Estefanía, Götz, Ralph, Doose, Sören, Sauer, Markus, Rodríguez Gil, Alfonso, Pérez Simón, José Antonio, Danhof, Sophia
المساهمون: Universidad de Sevilla. Departamento de Fisiología Médica y Biofísica, Universidad de Sevilla. Departamento de Medicina
مصطلحات موضوعية: Multiple myeloma, CD38 expression, HDAC6 inhibitors, Daratumumab
العلاقة: Leukemia, 35 (1), 201-214.; http://doi.org/10.1038/s41375-020-0840-yTest; https://idus.us.es/handle//11441/137450Test
-
4رسالة جامعية
المؤلفون: Almeida Parra, Ángeles
مرشدي الرسالة: Orfao, Alberto, Cordero Sánchez, Miguel, Almeida Parra, Julia María
مصطلحات موضوعية: Infección por VIH-1, Células presentadoras de antígeno, Células dendríticas, Monocitos, Linfocitos T, Tratamiento antirretroviral, Citocinas inflamatorias, Receptores de quimiocinas, Pacientes VIH-1+ que noprogresan a largo plazo (NPLP), Co-infección por VIH-1 y VHC, Inmunofenotipo, Activación inmune, Expresión de CD38, Análisis jerárquico de clusters, HIV-1 infection, Antigen presenting cells, Dendritic cells, Monocytes, T-lymphocytes, Antiretroviral therapy, Inflammatory cytokines, Chemokine receptors, Long-term non-progresor (LTNP) HIV-1+ patients, HIV-1 and HCV co-infection, Immunophenotype, Immune activation, CD38 expression, Hierarchical clustering analysis
الوصول الحر: http://hdl.handle.net/10366/22487Test
-
5رسالة جامعية
مرشدي الرسالة: Orfao, Alberto, Cordero Sánchez, Miguel, Almeida Parra, Julia María
مصطلحات موضوعية: Infección por VIH-1, Células presentadoras de antígeno, Células dendríticas, Monocitos, Linfocitos T, Tratamiento antirretroviral, Citocinas inflamatorias, Receptores de quimiocinas, Pacientes VIH-1+ que noprogresan a largo plazo (NPLP), Co-infección por VIH-1 y VHC, Inmunofenotipo, Activación inmune, Expresión de CD38, Análisis jerárquico de clusters, HIV-1 infection, Antigen presenting cells, Dendritic cells, Monocytes, T-lymphocytes, Antiretroviral therapy, Inflammatory cytokines, Chemokine receptors, Long-term non-progresor (LTNP) HIV-1+ patients, HIV-1 and HCV co-infection, Immunophenotype, Immune activation, CD38 expression, Hierarchical clustering analysis
الوصول الحر: http://hdl.handle.net/10366/22487Test
-
6دورية أكاديمية
المؤلفون: Frerichs, K.A., Minnema, M.C., Levin, M.D., Broijl, A., Bos, G.M.J., Kersten, M.J., Mutis, T., Verkleij, C.P.M., Nijhof, I.S., Maas-Bosman, P.W.C., Klein, S.K., Zweegman, S., Sonneveld, P., van de Donk, N.W.C.J.
المصدر: Frerichs , K A , Minnema , M C , Levin , M D , Broijl , A , Bos , G M J , Kersten , M J , Mutis , T , Verkleij , C P M , Nijhof , I S , Maas-Bosman , P W C , Klein , S K , Zweegman , S , Sonneveld , P & van de Donk , N W C J 2021 , ' Efficacy and safety of daratumumab combined with all-trans retinoic acid in relapsed/refractory multiple myeloma ' , Blood advances , vol. 5 , no. 23 ....
مصطلحات موضوعية: CD38 EXPRESSION, OPEN-LABEL, INTRAVENOUS DARATUMUMAB, UP-REGULATION, CELLS, DEXAMETHASONE, LENALIDOMIDE, MONOTHERAPY, BORTEZOMIB, EXPANSION
الإتاحة: https://doi.org/10.1182/bloodadvances.2021005220Test
https://cris.maastrichtuniversity.nl/en/publications/c3606b53-d789-4f48-9b36-6eac2bcf0b1fTest -
7دورية أكاديمية
المؤلفون: Weijun Wei (5905448), Di Zhang (197959), Cheng Wang (102692), You Zhang (522611), Shuxian An (5213276), Yumei Chen (3001587), Gang Huang (136671), Jianjun Liu (28194)
مصطلحات موضوعية: Biochemistry, Medicine, Hematology, Space Science, Environmental Sciences not elsewhere classified, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, positron emission tomography, may potentially optimize, e ., nb1053, bioorthogonal click chemistry, 6 ), respectively, 48 ± 0, 42 ± 0, 35 ± 0, annotating cd38 expression, work successfully developed, preclinical mm models, 18 sup, successfully labeled, n <, bearing models, reported probe, novel cd38, multiple myeloma, excellent immunoreactivity, established biomarker, disseminated mm
-
8دورية أكاديمية
المؤلفون: Ozbalak, Murat, Ozunal, Isil Erdogan, Berk, Selin, Elverdi, Tugrul, Salihoglu, Ayse, Eskazan, Ahmet Emre, Soysal, Teoman
مصطلحات موضوعية: Chronic lymphocytic leukemia, Killer immunoglobuline like receptor, autoimmunity, autoimmune hemolytic anemia, immune thrombocytopenic purpura, pure erythroid aplasia, Hemolytic-Anemia, T-Cells, Immune Thrombocytopenia, Prognostic-Significance, Cd38 Expression, Clinical-Course, Fludarabine, Susceptibility, Association, Cytopenia
وصف الملف: application/pdf
العلاقة: Journal Of Istanbul Faculty Of Medicine-Istanbul Tip Fakultesi Dergisi; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://doi.org/10.26650/IUITFD.2020.0037Test; https://hdl.handle.net/20.500.12831/6255Test; 84; 227; 236; WOS:000646763200012; 2-s2.0-85130336142; 415730
الإتاحة: https://doi.org/10.26650/IUITFD.2020.0037Test
https://doi.org/20.500.12831/6255Test
https://hdl.handle.net/20.500.12831/6255Test -
9
المؤلفون: Verkleij, Christie P. M., Frerichs, Kristine A., Broekmans, Marloes E. C., Duetz, Carolien, O'Neill, Chloe A., Bruins, Wassilis S. C., Homan-Weert, Paola M., Minnema, Monique C., Levin, Mark-David, Broijl, Annemiek, Bos, Gerard M. J., Kersten, Marie José, Klein, Saskia K., Shikhagaie, Medya M., Casneuf, Tineke, Abraham, Yann, Smets, Tina, Vanhoof, Greet, Cortes-Selva, Diana, van Steenbergen, Laure, Ramos, Elena, Verona, Raluca I., Krevvata, Maria, Sonneveld, Pieter, Zweegman, Sonja, Mutis, Tuna, van de Donk, Niels W. C. J.
المساهمون: Hematology, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Hematologie (9), Internal medicine, Hematology laboratory, Anatomy and neurosciences, AII - Cancer immunology, CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology
المصدر: Verkleij, C P M, Frerichs, K A, Broekmans, M E C, Duetz, C, O'Neill, C A, Bruins, W S C, Homan-Weert, P M, Minnema, M C, Levin, M-D, Broijl, A, Bos, G M J, Kersten, M J, Klein, S K, Shikhagaie, M M, Casneuf, T, Abraham, Y, Smets, T, Vanhoof, G, Cortes-Selva, D, van Steenbergen, L, Ramos, E, Verona, R I, Krevvata, M, Sonneveld, P, Zweegman, S, Mutis, T & van de Donk, N W C J 2023, ' NK Cell Phenotype Is Associated With Response and Resistance to Daratumumab in Relapsed/Refractory Multiple Myeloma ', HemaSphere, vol. 7, no. 5, pp. E881 . https://doi.org/10.1097/HS9.0000000000000881Test
HemaSphere, 7(5):E881. Wolters Kluwer Health
HemaSphere, 7(5):e881. Wolters Kluwer Health
HemaSphere, 7(5). Wolters Kluwer Healthمصطلحات موضوعية: NATURAL-KILLER-CELLS, CD38 EXPRESSION, LENALIDOMIDE, OUTCOMES, MONOTHERAPY, EXPANSION, Hematology, T-CELL, EFFICACY, COMBINATION, THERAPY
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d49ed4ae501b62a9d60de96d65169e2Test
https://research.vumc.nl/en/publications/6385dc8c-ee58-4214-9d1f-1b3ffc0e0d0eTest -
10
المؤلفون: Pier Luigi Zinzani, Anna Sureda, Cecilia Carpio, Krimo Bouabdallah, Robin Meng, Guillaume Cartron, Marjolein van der Poel, Su-Peng Yeh, Raul Cordoba, Alessandro Re, Armando López-Guillermo, Lucie Lepine, Youngil Koh, Steven Le Gouill, Giovanni Abbadessa, Luís Francisco Araújo, Vincent Ribrag, Martine E D Chamuleau, Olivier Casasnovas, Ran Ji, Rao Saleem, Won Seog Kim, Maria Ilidia Moreira, Daniela Alves, Carmelo Carlo-Stella
المساهمون: RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: MA Hematologie (9), Institut Català de la Salut, [Carlo-Stella C] Department of Biomedical Sciences, Humanitas University and Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Milano, Italy. [Zinzani PL] IRCCS Azienda Ospedaliero‐Universitaria di Bologna Istituto di Ematologia 'Seràgnoli' and Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna, Bologna, Italy. [Sureda A] Institut Català D'Oncologia ‐ Hospital Duran i Reynals, IDIBELL, Universitat de Barcelona, Barcelona, Spain. [Araújo L] Universitário de Coimbra, Coimbra, Portugal. [Casasnovas O] Hématologie Clinique, CHU Dijon Bourgogne, Dijon, France. [Carpio C] Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain, Vall d'Hebron Barcelona Hospital Campus, Hematology, CCA - Cancer Treatment and quality of life, CCA - Cancer biology and immunology
المصدر: Hematological Oncology, 41(1), 108-119. Wiley
Scientia
Carlo-Stella, C, Zinzani, P L, Sureda, A, Araújo, L, Casasnovas, O, Carpio, C, Yeh, S-P, Bouabdallah, K, Cartron, G, Kim, W S, Cordoba, R, Koh, Y, Re, A, Alves, D, Chamuleau, M, le Gouill, S, López-Guillermo, A, Moreira, I, van der Poel, M W M, Abbadessa, G, Meng, R, Ji, R, Lépine, L, Saleem, R & Ribrag, V 2022, ' A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma ', Hematological Oncology . https://doi.org/10.1002/hon.3089Test
Hematological Oncology. John Wiley and Sons Ltdمصطلحات موضوعية: Cancer Research, medicine.medical_specialty, BONE-MARROW, Immunology, diffuse large B-cell lymphoma, Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Antibodies, Monoclonal::Antibodies, Monoclonal, Humanized [CHEMICALS AND DRUGS], Biochemistry, Gastroenterology, BRENTUXIMAB VEDOTIN, HODGKIN-LYMPHOMA, Hodgkin, Malaltia de - Tractament, Internal medicine, Phase (matter), MULTIPLE-MYELOMA, Medicine, Neoplasms::Neoplasms by Histologic Type::Lymphoma::Lymphoma, Non-Hodgkin::Lymphoma, T-Cell::Lymphoma, T-Cell, Peripheral [DISEASES], aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::anticuerpos monoclonales::anticuerpos monoclonales humanizados [COMPUESTOS QUÍMICOS Y DROGAS], In patient, Other subheadings::/therapeutic use [Other subheadings], peripheral T-cell lymphoma, CELL LYMPHOMA, Isatuximab, neoplasias::neoplasias por tipo histológico::linfoma::linfoma no Hodgkin::linfoma de células T::linfoma de células T periféricas [ENFERMEDADES], Anticossos monoclonals - Ús terapèutic, Otros calificadores::/uso terapéutico [Otros calificadores], business.industry, non-Hodgkin lymphoma, NIVOLUMAB, SAR650984, General Medicine, Cell Biology, Hematology, medicine.disease, neoplasias::neoplasias por tipo histológico::linfoma::enfermedad de Hodgkin [ENFERMEDADES], Lymphoma, CD38 EXPRESSION, Oncology, Multicenter study, Limfomes - Tractament, cemiplimab, Open label, business, Neoplasms::Neoplasms by Histologic Type::Lymphoma::Hodgkin Disease [DISEASES], isatuximab
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::086237dc28c03b5f031a7a993d237717Test
https://cris.maastrichtuniversity.nl/en/publications/5d163f18-ed7b-45ef-b334-d47a337fea84Test